SwissNeuroRehab wins grant to build new treatment models for stroke, TBI

SwissNeuroRehab, a collaborative effort led by Lausanne University Hospital to advance neurorehabilitation treatment across continuum of care, has won the Innosuisse Flagship award, according to a release.

The group will leverage more than 11.2 million CHF (12.2 million USD) toward creating therapeutic programs that safely and effectively combine the latest digital therapeutics and neurotechnology.

“With SwissNeuroRehab, we will set out to test novel digital therapeutic interventions for the treatment of neurological disease and neurological injury,” John Krakauer, MD, chief medical and scientific advisor at Swiss neurotechnology firm and project partner MindMaze, said in the release.

Along with MindMaze, SwissNeuroRehab is a collaboration among university hospitals, rehabilitation clinics, inpatient and outpatient providers, technical schools and other industry partners.

The project aims to create an effective and efficient model of neurorehabilitation focusing on stroke, traumatic brain injury and spinal cord injury, as well as a patient-centered model that will identify requirements needed to effectively treat physical and cognitive effects following stroke or injury.

Concurrent with therapeutic goals, the project will propose a reimbursement system and new educational curricula for health care professionals, patients and caregivers to implement in their respective disciplines.

“The model will offer a long-term solution for acquired neurological injuries in the Swiss health system first, but its innovative ambition can develop solutions that can apply universally,” Andrea Serino, project coordinator of SwissNeuroRehab at Lausanne University Hospital, said in the release. “We look forward to piloting a model that will then generalize globally.”